372 related articles for article (PubMed ID: 34479773)
1. Antifibrotic effects and mechanisms of mesenchymal stem cell-derived exosomes in a systemic sclerosis mouse model: Possible contribution of miR-196b-5p.
Baral H; Uchiyama A; Yokoyama Y; Sekiguchi A; Yamazaki S; Amalia SN; Inoue Y; Ogino S; Torii R; Hosoi M; Matsuzaki T; Motegi SI
J Dermatol Sci; 2021 Oct; 104(1):39-47. PubMed ID: 34479773
[TBL] [Abstract][Full Text] [Related]
2. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H
J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow mesenchymal stem cell-derived exosomes alleviate skin fibrosis in systemic sclerosis by inhibiting the IL-33/ST2 axis via the delivery of microRNA-214.
Xie L; Long X; Mo M; Jiang J; Zhang Q; Long M; Li M
Mol Immunol; 2023 May; 157():146-157. PubMed ID: 37028129
[TBL] [Abstract][Full Text] [Related]
4. Exosomes derived from mesenchymal stem cells ameliorate renal fibrosis via delivery of miR-186-5p.
Yang Y; Wang J; Zhang Y; Hu X; Li L; Chen P
Hum Cell; 2022 Jan; 35(1):83-97. PubMed ID: 34585365
[TBL] [Abstract][Full Text] [Related]
5. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI
Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
[TBL] [Abstract][Full Text] [Related]
6. Exosomes Derived from Human Adipose Mesenchymal Stem Cells Inhibits Fibrosis and Treats Oral Submucous Fibrosis via the miR-181a-5p/Smad2 Axis.
Shao Z; Xu J; Xu X; Wang X; Zhou Y; Li Y; Li K
Tissue Eng Regen Med; 2024 Jan; 21(1):123-135. PubMed ID: 37755664
[TBL] [Abstract][Full Text] [Related]
7. The compound LG283 inhibits bleomycin-induced skin fibrosis via antagonizing TGF-β signaling.
Utsunomiya A; Chino T; Kasamatsu H; Hasegawa T; Utsunomiya N; Luong VH; Matsushita T; Sasaki Y; Ogura D; Niwa SI; Oyama N; Hasegawa M
Arthritis Res Ther; 2022 Apr; 24(1):94. PubMed ID: 35488265
[TBL] [Abstract][Full Text] [Related]
8. Exosomes derived from miR-16-5p-overexpressing keratinocytes attenuates bleomycin-induced skin fibrosis.
Bo Y; Liu B; Yang L; Zhang L; Yan Y
Biochem Biophys Res Commun; 2021 Jul; 561():113-119. PubMed ID: 34022711
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Disabled-2 on skin fibrosis in systemic sclerosis.
Mei X; Zhao H; Huang Y; Tang Y; Shi X; Pu W; Jiang S; Ma Y; Zhang Y; Bai L; Tu W; Zhao Y; Jin L; Wu W; Wang J; Liu Q
J Dermatol Sci; 2020 Jul; 99(1):44-52. PubMed ID: 32571632
[TBL] [Abstract][Full Text] [Related]
11. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
[TBL] [Abstract][Full Text] [Related]
12. TNF-α-induced exosomal miR-146a mediates mesenchymal stem cell-dependent suppression of urethral stricture.
Liang YC; Wu YP; Li XD; Chen SH; Ye XJ; Xue XY; Xu N
J Cell Physiol; 2019 Dec; 234(12):23243-23255. PubMed ID: 31144307
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis.
Jiang Y; Hu F; Li M; Li Q
Clin Exp Pharmacol Physiol; 2024 Feb; 51(2):e13834. PubMed ID: 38037494
[TBL] [Abstract][Full Text] [Related]
14. The involvement of leucine-rich α-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model.
Nakajima H; Nakajima K; Serada S; Fujimoto M; Naka T; Sano S
Mod Rheumatol; 2021 Nov; 31(6):1120-1128. PubMed ID: 33535851
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cell-Derived Exosomes Ameliorate Dermal Fibrosis in a Murine Model of Bleomycin-Induced Scleroderma.
Li M; Zhang HP; Wang XY; Chen ZG; Lin XF; Zhu W
Stem Cells Dev; 2021 Oct; 30(19):981-990. PubMed ID: 34428952
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX
Luong VH; Utsunomiya A; Chino T; Doanh LH; Matsushita T; Obara T; Kuboi Y; Ishii N; Machinaga A; Ogasawara H; Ikeda W; Kawano T; Imai T; Oyama N; Hasegawa M
Arthritis Rheumatol; 2019 Nov; 71(11):1923-1934. PubMed ID: 31173491
[TBL] [Abstract][Full Text] [Related]
18. Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing.
Fang S; Xu C; Zhang Y; Xue C; Yang C; Bi H; Qian X; Wu M; Ji K; Zhao Y; Wang Y; Liu H; Xing X
Stem Cells Transl Med; 2016 Oct; 5(10):1425-1439. PubMed ID: 27388239
[TBL] [Abstract][Full Text] [Related]
19. Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts.
Wermuth PJ; Piera-Velazquez S; Jimenez SA
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):21-30. PubMed ID: 28094758
[TBL] [Abstract][Full Text] [Related]
20. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
